PDCD1 and gastric cancer: However, not all gastric cancer patients can benefit from PD-1 inhibitors.The response rate of tumors to PD-1 inhibitors varies with the microsatellite stability, the degree of immune cell infiltration, the level of PD-L1 expression and so on (6).